financetom
Business
financetom
/
Business
/
TUI boss: we will use partner airlines when facing strong demand
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
TUI boss: we will use partner airlines when facing strong demand
Feb 21, 2025 9:19 AM

LONDON, Feb 21 (Reuters) - The boss of Europe's largest

tour operator, TUI, said on Friday it would use partner airlines

like Ryanair to carry passengers when it is facing strong

demand, enabling it to remain conservative on its own airline

schedule.

Despite the continuing post-pandemic demand for travel, a

number of airlines have had to limit capacity growth targets

because of delivery delays from plane makers, which are still

grappling with supply-chain challenges.

"If you look at the package model, we are conservative in

capacity, we envisaged the market would be more competitive this

year," TUI CEO Sebastian Ebel told reporters in London.

Competition from easyJet and British Airways in the

packaged-holidays businesses has grown across the European

market.

"We want to sell with a good margin, at times where there is

oversupply we will benefit from dynamic access to these

suppliers," Ebel said.

In terms of demand, he said Turkey, once a popular cheap

destination for British and European tourists, was becoming less

so due to higher costs.

GROWTH

TUI wants to expand beyond its packaged-holiday business,

becoming more resilient through a wider offering of amusement

and experience packages via an app.

Ebel compared the business model to that of U.S. internet

giant Amazon ( AMZN ).

"They started with books, and then they grew in all kinds of

other products. Our core is leisure, but it's not only sun and

beach, it's everything about leisure," he told Reuters on the

sidelines of the roundtable.

He added that the company wanted to expand its offering in

more distant destinations like Southeast Asia, China and,

eventually, Latin America.

"We are building a portfolio where we don't depend on one

market or two markets - we can depend on a lot of markets," he

said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2025 - www.financetom.com All Rights Reserved